Showing results (121-130 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|October 3, 2002
No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitorsArtur-Aron Weber, Collin Jacobs, Dan Meila, et al.Pharmacogenetics|June 4, 2002
The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoterFabrice Morel, Claudine Rauch, Brian Coles, et al.Pharmacogenetics|August 16, 2001
Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substratesY Ramamoorthy, R F Tyndale, E M SellersPharmacogenetics|April 1, 1993
2,3,7,8-Tetrachlorodibenzo-p-dioxin induces the nuclear translocation of two XRE binding proteins in miceS T Okino, U R Pendurthi, R H TukeyPharmacogenetics|June 1, 1995
Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafnessC Bacino, T R Prezant, X Bu, et al.Pharmacogenetics|October 1, 1995
Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adultsH L McLeod, E Y Krynetski, J A Wilimas, et al.Pharmacogenetics|June 1, 1996
Nomenclature for human CYP2D6 allelesA K Daly, J Brockmöller, F Broly, et al.Pharmacogenetics|June 1, 1996
Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotypeV Carrière, F Berthou, S Baird, et al.Pharmacogenetics|September 30, 2003
Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer statusMurray L Barclay, Steven M Sawyers, Evan J Begg, et al.Pharmacogenetics|September 30, 2003
Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy menTerho Lehtimäki, Reijo Laaksonen, Tuula Janatuinen, et al.Pageof 83